Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€709.60
02.04.24
€831.01
02.04.25
-0.97%
16.04.24

Citigroup Inc. 
02.04.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.11
02.04.24
-
02.04.25
-38.74%
16.04.24

Could be very worthwhile Investment >20% year
thomasw 
02.04.24 50%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.37
02.04.24
€19.50
02.04.25
0.00%
02.04.24

HC Wainwright 
02.04.24 50%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.14
02.04.24
-
02.04.25
-28.14%
13.04.24

Could be worthwhile Investment >10% per year
melinda 
02.04.24 10%
buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€154.20
02.04.24
€180.96
02.04.25
-6.58%
16.04.24

Stifel Nicolaus 
02.04.24 50%
buy
Trevena Inc.

Start price
Target price
Perf. (%)
€0.33
02.04.24
€8.37
02.04.25
9.82%
16.04.24

HC Wainwright 
02.04.24 50%
sell
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.01
02.04.24
-
02.04.25
-8.41%
16.04.24

Probably not worthwhile Investment
Higher risks for its business
Lokrim 
02.04.24 20%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.28
02.04.24
-
02.04.25
-42.75%
16.04.24

Probably not worthwhile Investment
Below average Marketposition
Higher risks for its business
Lokrim 
02.04.24 20%
sell
Evoke Pharma Inc.

Start price
Target price
Perf. (%)
€0.56
02.04.24
-
02.04.25
-15.32%
15.04.24

StockNews.com 
02.04.24 50%
sell
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€1.60
02.04.24
-
02.04.25
-48.88%
13.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
02.04.24 0%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€200.90
01.04.24
-
01.04.25
-8.54%
16.04.24

William Blair 
01.04.24 50%
buy
Insmed Inc.

Start price
Target price
Perf. (%)
€24.80
01.04.24
€51.22
01.04.25
8.06%
15.04.24

Wells Fargo & Company 
01.04.24 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
01.04.24
€23.28
01.04.25
-
08.03.24

Wells Fargo & Company 
01.04.24 50%
buy
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€1.67
01.04.24
-
01.04.25
-15.77%
16.04.24

Cantor Fitzgerald 
01.04.24 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
01.04.24
-
01.04.25
-
08.03.24

Cantor Fitzgerald 
01.04.24 50%
buy
Alkermes plc

Start price
Target price
Perf. (%)
€25.60
01.04.24
€36.29
01.04.25
-12.50%
15.04.24

Piper Sandler 
01.04.24 50%
buy
Kala Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.29
01.04.24
€13.96
01.04.25
1.10%
02.04.24

Oppenheimer Holdings Inc. 
01.04.24 50%
buy
Durect Corp.

Start price
Target price
Perf. (%)
€0.37
01.04.24
€4.65
01.04.25
-
05.12.22

Oppenheimer Holdings Inc. 
01.04.24 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€25.86
01.04.24
€41.73
01.04.25
-6.38%
16.04.24

Cantor Fitzgerald 
01.04.24 50%
buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€120.00
01.04.24
€148.38
01.04.25
-2.92%
16.04.24

Cantor Fitzgerald 
01.04.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€712.00
01.04.24
€755.83
01.04.25
-1.31%
16.04.24

Cantor Fitzgerald 
01.04.24 50%
buy
SCYNEXIS Inc.

Start price
Target price
Perf. (%)
€1.50
01.04.24
-
01.04.25
-8.07%
15.04.24

Cantor Fitzgerald 
01.04.24 50%
buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€5.70
01.04.24
€15.77
01.04.25
-13.33%
16.04.24

Truist Financial Co. 
01.04.24 50%
buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.70
01.04.24
€13.91
01.04.25
11.70%
16.04.24

HC Wainwright 
01.04.24 50%
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€0.55
01.04.24
€9.27
01.04.25
-
08.03.24

HC Wainwright 
01.04.24 50%